COMMUNIQUÉS West-GlobeNewswire

-
Major shareholding announcement
16/08/2018 -
Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option
16/08/2018 -
Rafael Pharmaceuticals Receives FDA Orphan Drug Designation of CPI-613 for the Treatment of Peripheral T-Cell Lymphoma (PTCL)
16/08/2018 -
Bio-Path Holdings Appoints Dr. Jason B. Fleming to Scientific Advisory Board
16/08/2018 -
Decisions of the Extraordinary General Meeting of Biohit Oyj
16/08/2018 -
CBT Pharmaceuticals Announces New Leadership Structure to Drive Global Expansion
16/08/2018 -
FIT Biotech Oy: FIT Biotech concludes the exploration of secondary listing to First North Sweden -not relevant at the moment
16/08/2018 -
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
16/08/2018 -
Zealand Pharma - Interim report for the first half of 2018
16/08/2018 -
FIT Biotech Oy: Chairman of the board on leave of absence
16/08/2018 -
ATW Tech Announces the Release of the New Branding for Its Voting System
16/08/2018 -
ATW Tech annonce le lancement de sa nouvelle marque pour son système de votation
16/08/2018 -
Agritek Holdings, Inc. Announces Filing Extension And Delay In Form 10-Q Report With Full Intention Of Remaining Fully Reporting And Uplisted On OTCQB
16/08/2018 -
Hemostemix Announces Two New Strategic Trial Sites in Texas
16/08/2018 -
FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management
16/08/2018 -
Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review
16/08/2018 -
Terra Tech Corp. CEO Derek Peterson to speak at Upcoming Cannabis Events
16/08/2018 -
Iovance Biotherapeutics Announces Clinical Trial Updates with Collaborators MD Anderson and Moffitt Cancer Center
16/08/2018 -
Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab
16/08/2018
Pages